There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

The severity of left ventricular diastolic dysfunction affects risk for incident stroke and transient ischemic attack, as well as major bleeding.

CHARLESTOWN, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SLDB) (the “Company”), a life sciences company developing ...

Amavita has started using AISAP’s AI-powered POCUS diagnostic in community settings for aortic stenosis screening.

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...

Black and Hispanic patients have increased mortality rates and lower rates of coronary interventions following in-hospital cardiac arrest.

EBR Systems is super confident the US medical gatekeeper will approve Wise, the world's first wireless pacemaker device.

Researchers have found in a new study that receiving an implantable cardioverter-defibrillator (ICD) within the last six ...

Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

Due to uncertainty within the data, the impact of looser driving restrictions still merits close scrutiny, a researcher says.